Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Altimmune Inc.

    NASDAQ: ALT · Real-Time Price · USD
    6.84
    -0.08 (-1.16%)
    At close: Jun 16, 2025, 3:59 PM
    6.95
    1.53%
    After-hours: Jun 16, 2025, 07:56 PM EDT
    -1.16%
    Bid 5.22
    Market Cap 555.18M
    Revenue (ttm) 20K
    Net Income (ttm) -90.24M
    EPS (ttm) -1.26
    PE Ratio (ttm) -5.43
    Forward PE -5.29
    Analyst Buy
    Ask 8.76
    Volume 3,820,534
    Avg. Volume (20D) 2,576,236
    Open 7.06
    Previous Close 6.92
    Day's Range 6.79 - 7.37
    52-Week Range 3.55 - 11.16
    Beta 0.57

    About ALT

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol ALT
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for ALT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    3 months ago
    +13.85%
    Altimmune shares are trading higher amid rumours s... Unlock content with Pro Subscription
    3 months ago
    +8.08%
    Altimmune shares are trading higher. The company reported Q4 financial results.
    news image

    5 days ago · accessnewswire.com

    ALT5 Sigma to Exhibit at iFX EXPO International June 17-19, 2025

    LAS VEGAS, NV / ACCESS Newswire / June 11, 2025 / ALT5 Sigma Corporation (NASDAQ:ALTS)(FRA:5AR1), a fintech specializing in turnkey, crypto-related solutions for institutions and merchants, is pleased...

    news image

    2 weeks ago · seekingalpha.com

    Altimmune Vs. Viking Therapeutics: Evaluating Pipeline Maturity, And Takeover Potential

    I rate Altimmune a 'Strong Buy' and Viking Therapeutics a 'Buy' for high-risk, long-term investors. ALT's Pemvidutide stands out for its lean mass protection, visceral fat reduction, and potential in ...

    news image

    2 weeks ago · seekingalpha.com

    Altimmune: Upcoming MASH Data Could Be High Impact For Business Development Activity

    ALT is approach a readout from IMPACT, a phase 2b study of pemvidutide in MASH. MDGL's results with its launch of MASH drug Rezdiffra demonstrate the multi-billion-dollar potential of a MASH drug, alt...

    news image

    2 weeks ago · accessnewswire.com

    ALT5 Sigma Launches Lightning Network Integration to Power Instant Bitcoin and Tether Payments in Partnership with Voltage

    Support for Bitcoin and Stablecoins on Lightning Underscores ALT5's Commitment to Scalable, Real-Time Settlement Infrastructure LAS VEGAS, NEVADA / ACCESS Newswire / May 27, 2025 / ALT5 Sigma Corporat...

    news image

    3 weeks ago · accessnewswire.com

    ALT5 Sigma Corporation Announces Record Date for Alyea Therapeutics Corporation Transaction

    LAS VEGAS, NEVADA / ACCESS Newswire / May 21, 2025 / ALT5 Sigma Corporation (the "Company" or "ALT5") (NASDAQ:ALTS)(FRA:5AR1), a fintech, providing next generation blockchain-powered technologies for ...

    news image

    1 month ago · seekingalpha.com

    Altimmune, Inc. (ALT) Q1 2025 Earnings Call Transcript

    Altimmune, Inc. (NASDAQ:ALT ) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Lee Roth - President, Burns McClellan, Investor Relations Advisors Vipin Garg - Chief Execut...

    news image

    1 month ago · accessnewswire.com

    ALT5 Sigma Reports Record First Quarter 2025 and Announces Acquisition of Mswipe

    Reports third consecutive record quarter for Fintech segment Mswipe acquisition, expected to close early in Q2, will be immediately accretive upon close to revenue and EBITDA Payment Card offering, al...

    news image

    1 month ago · accessnewswire.com

    ALT5 Sigma Sponsors Consensus 2025, Showcasing Crypto Infrastructure Built for Real-World Finance

    ALT5 Sigma brings regulated rails and next-gen payment infrastructure to the biggest stage in crypto LAS VEGAS, NEVADA / ACCESS Newswire / May 9, 2025 / ALT5 Sigma Corporation (NASDAQ:ALTS)(FRA:5AR1),...

    news image

    1 month ago · zacks.com

    How Much Upside is Left in Altimmune (ALT)? Wall Street Analysts Think 285.86%

    The mean of analysts' price targets for Altimmune (ALT) points to a 285.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analys...

    news image

    2 months ago · accessnewswire.com

    ALT5 Sigma Launches Crypto-as-a-Service Offering, Enabling FINRA Members, Banks, and Credit Unions to Rapidly Deploy Compliant Digital Asset Trading Capabilities

    ALT5 joins the Securities Industry and Financial Markets Association (SIFMA) LAS VEGAS, NV / ACCESS Newswire / April 10, 2025 / ALT5 Sigma Corporation (NASDAQ:ALTS)(FRA:5AR1), a fintech specializing i...

    Add to Watchlist